uniQure N.V. (QURE) - 5i Research

uniQure N.V. (QURE $16.09)
- $16.09 Cap: $996M
- View QURE Profile
- View Questions on QURE

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

uniQure N.V. (QURE $16.09)
- $16.09 Cap: $996M
- View QURE Profile
- View Questions on QURE
Doximity Inc. Class A (DOCS $24.41)
- $24.41 P/E (TTM): 20.67X Cap: $4.50B
- View DOCS Profile
- View Questions on DOCS
ADMA Biologics Inc (ADMA $14.32)
- $14.32 P/E (TTM): 25.03X Cap: $3.84B
- View ADMA Profile
- View Questions on ADMA
National HealthCare Corporation (NHC $158.81)
- $158.81 P/E (TTM): 20.56X Cap: $2.50B
- View NHC Profile
- View Questions on NHC
Corvus Pharmaceuticals Inc. (CRVS $13.33)
- $13.33 Cap: $1.28B
- View CRVS Profile
- View Questions on CRVS

Q: Hi team,

In attempting to increase the health sector and possibly the international percentage of my portfolio, I am considering the following stocks: ADMA,NHC, QURE,DOCS, CRVS.

Would you recommend any of these or any others for a growth portfolio at this time ?

Gratefully,

Jacques IDS

Read Answer Asked by Jacques on March 16, 2026

Micron Technology Inc. (MU $422.90)
- $422.90 P/E (TTM): 42.23X Cap: $475.97B
- View MU Profile
- View Questions on MU
Advanced Micro Devices Inc. (AMD $201.33)
- $201.33 P/E (TTM): 77.46X Cap: $328.25B
- View AMD Profile
- View Questions on AMD
uniQure N.V. (QURE $16.09)
- $16.09 Cap: $996M
- View QURE Profile
- View Questions on QURE
Lemonade Inc. (LMND $64.18)
- $64.18 Cap: $4.90B
- View LMND Profile
- View Questions on LMND
MP Materials Corp. (MP $50.60)
- $50.60 Cap: $8.98B
- View MP Profile
- View Questions on MP
AST SpaceMobile Inc. (ASTS $89.93)
- $89.93 Cap: $34.35B
- View ASTS Profile
- View Questions on ASTS
IREN Limited (IREN $41.29)
- $41.29 P/E (TTM): 74.39X Cap: $13.71B
- View IREN Profile
- View Questions on IREN
Rocket Lab Corporation (RKLB $67.23)
- $67.23 Cap: $38.28B
- View RKLB Profile
- View Questions on RKLB

Q: RKNG This brand new Defiance ETF holds some high growth names. Could you examine the current holdings and provide your view on the potential here. Ms Jablonski has some vision so could this be a reasonable high risk small piece of one's portfolio in your view.

Read Answer Asked by Ken on January 26, 2026

AbbVie Inc. (ABBV $205.07)
- $205.07 P/E (TTM): 87.39X Cap: $362.59B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $906.70)
- $906.70 P/E (TTM): 39.98X Cap: $856.66B
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $16.57)
- $16.57 P/E (TTM): 18.32X Cap: $418M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $63.43)
- $63.43 P/E (TTM): 25.01X Cap: $7.48B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $16.09)
- $16.09 Cap: $996M
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $22.79)
- $22.79 P/E (TTM): 13.21X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025